|
3S95
Crystal structure of the human LIMK1 kinase domain in complex with staurosporine
Deposited 2011-05-31
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
330–637(308 aa)
Fragment:kinase domain (residue 330-637)
|
Not recorded
|
STU STAUROSPORINE × 1
NA SODIUM ION × 1
GOL GLYCEROL × 9
CL CHLORIDE ION × 1
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.2;293.15 K;24% MPD, 0.1M Tris pH 7.2, 10mM Phenol, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 1.65 Å
R-free 0.181
|
|
3S95
Crystal structure of the human LIMK1 kinase domain in complex with staurosporine
Deposited 2011-05-31
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
330–637(308 aa)
Fragment:kinase domain (residue 330-637)
|
Not recorded
|
STU STAUROSPORINE × 1
NA SODIUM ION × 1
GOL GLYCEROL × 2
CL CHLORIDE ION × 1
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.2;293.15 K;24% MPD, 0.1M Tris pH 7.2, 10mM Phenol, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 1.65 Å
R-free 0.181
|
|
5HVJ
Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP
Deposited 2016-01-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
329–638(310 aa)
|
Mutation:D460N
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;18-24% PEG 3350, 0.2 M potassium citrate
|
Resolution 2.20 Å
R-free 0.252
|
|
5HVJ
Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP
Deposited 2016-01-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
329–638(310 aa)
|
Mutation:D460N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;18-24% PEG 3350, 0.2 M potassium citrate
|
Resolution 2.20 Å
R-free 0.252
|
|
5HVK
Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1
Deposited 2016-01-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
329–638(310 aa)
Fragment:UNP residues 329-638
|
Mutation:D460N
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;1.2-1.4 M tri-Sodium citrate, 0.1 M sodium acetate, pH 5.5.
4 crystals used.
|
Resolution 3.50 Å
R-free 0.310
|
|
5HVK
Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1
Deposited 2016-01-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
329–638(310 aa)
Fragment:UNP residues 329-638
|
Mutation:D460N
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;1.2-1.4 M tri-Sodium citrate, 0.1 M sodium acetate, pH 5.5.
4 crystals used.
|
Resolution 3.50 Å
R-free 0.310
|
|
5L6W
Structure Of the LIMK1-ATPgammaS-CFL1 Complex
Deposited 2016-05-31
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
330–637(308 aa)
|
Not recorded
|
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;35% pentaerythritol propoxylate 5/4, 0.1 M HEPES pH 7.5, 0.2 M potassium chloride
|
Resolution 2.53 Å
R-free 0.284
|
|
5NXC
LIM Domain Kinase 1 (LIMK1) In Complex With PF-00477736
Deposited 2017-05-10
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain L
330–637(308 aa)
Fragment:UNP residues 330-637
|
Not recorded
|
9DB (2~{R})-2-azanyl-2-cyclohexyl-~{N}-[2-(1-methylpyrazol-4-yl)-9-oxidanylidene-3,10,11-triazatricyclo[6.4.1.0^{4,13}]trideca-1,4,6,8(13),11-pentaen-6-yl]ethanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;0.1 M HEPES pH 7.0
0.2 M MgCl2
10% PEG8K
|
Resolution 2.25 Å
R-free 0.298
|
|
6WLY
PAK4 kinase domain in complex with LIMK1 Thr508 substrate peptide
Deposited 2020-04-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
503–512(10 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;295 K;0.1M Tris-HCl, 2M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K, 2mM peptide
|
Resolution 1.90 Å
R-free 0.205
|
|
7ATS
The LIMK1 Kinase Domain Bound To LIJTF500127
Deposited 2020-10-30
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
330–637(308 aa)
|
Not recorded
|
RXQ N-[3-[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]benzenesulfonamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG3350
0.1 M bis-tris-propane pH 7.5
0.2 M potassium thiocyanate
10% ethylene glycol
|
Resolution 2.80 Å
R-free 0.312
|
|
7ATU
The LIMK1 Kinase Domain Bound To LIJTF500025
Deposited 2020-10-30
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomer
|
Chain A
330–637(308 aa)
|
Not recorded
|
RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride
|
Resolution 2.80 Å
R-free 0.316
|
|
7ATU
The LIMK1 Kinase Domain Bound To LIJTF500025
Deposited 2020-10-30
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomer
|
Chain B
330–637(308 aa)
|
Not recorded
|
RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride
|
Resolution 2.80 Å
R-free 0.316
|
|
7ATU
The LIMK1 Kinase Domain Bound To LIJTF500025
Deposited 2020-10-30
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomer
|
Chain C
330–637(308 aa)
|
Not recorded
|
RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride
|
Resolution 2.80 Å
R-free 0.316
|
|
7ATU
The LIMK1 Kinase Domain Bound To LIJTF500025
Deposited 2020-10-30
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomer
|
Chain D
330–637(308 aa)
|
Not recorded
|
RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride
|
Resolution 2.80 Å
R-free 0.316
|
|
8AAU
LIM Domain Kinase 1 (LIMK1) bound to LIMKi3
Deposited 2022-07-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain L
330–637(308 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
LH0 ~{N}-[5-[2-[2,6-bis(chloranyl)phenyl]-5-[bis(fluoranyl)methyl]pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methyl-propanamide × 1
SO4 SULFATE ION × 3
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;277 K;0.1 M acetate pH 4.5, 0.2 M lithium sulfate, 12% PEG8K
|
Resolution 1.74 Å
R-free 0.240
|